CORMEDIX INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
CORMEDIX INC. (CRMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 31.95 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2023-03-30
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-06-30 was 4.50K shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-03-31 was 6.00K shares, a 12.93% decline year-over-year.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-09-30 was 0.00 shares.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 31.95K shares, a 87.11% decline from fiscal 2021.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 248.00K shares, a 3498.91% increase from fiscal 2020.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2020 was 6.89K shares, a 2.85% decline from fiscal 2019.
- CORMEDIX INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 7.09K shares, a 98.44% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2022-12-31 | 31.95K shares 10-K · filed 2023-03-30 | |||
| 2021-12-31 | 248.00K shares 10-K · filed 2022-03-29 | |||
| 2021-06-30 | 4.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 10.50K shares 10-Q · filed 2021-08-12 | 10.50K shares derived: sum of 3 quarters · filed 2021-08-12 | 10.50K shares derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | 6.00K shares 10-Q · filed 2021-05-13 | 6.00K shares derived: sum of 2 quarters · filed 2021-05-13 | 6.00K shares derived: sum of 3 quarters · filed 2021-05-13 | 6.00K shares derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-30 | 6.89K shares 10-K · filed 2021-03-30 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-05 | 6.89K shares 10-Q · filed 2020-11-05 | 13.81K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 6.89K shares 10-Q · filed 2020-08-10 | 13.81K shares derived: sum of 3 quarters · filed 2020-08-10 | 13.81K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 6.89K shares 10-Q · filed 2020-05-11 | 13.81K shares derived: sum of 2 quarters · filed 2020-05-11 | 13.81K shares derived: sum of 3 quarters · filed 2020-05-11 | |
| 2019-12-31 | 6.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 6.92K shares derived: sum of 2 quarters · filed 2020-03-16 | 7.09K shares 10-K · filed 2020-03-16 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 177.00 shares 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | 177.00 shares 10-Q · filed 2019-08-14 | |||
| 2018-12-31 | 364.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-29 | 423.12K shares derived: sum of 2 quarters · filed 2019-05-29 | 453.94K shares 10-K · filed 2019-05-29 | |
| 2018-09-30 | 58.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 89.57K shares 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | 30.82K shares 10-Q · filed 2018-08-14 | |||
| 2017-12-31 | -126.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | 408.41K shares derived: sum of 2 quarters · filed 2018-03-19 | 408.41K shares derived: sum of 3 quarters · filed 2018-03-19 | 436.12K shares 10-K · filed 2018-03-19 |
| 2017-09-30 | 535.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 535.00K shares derived: sum of 2 quarters · filed 2017-11-09 | 562.71K shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 27.71K shares 10-Q · filed 2017-08-09 | ||
| 2017-03-31 | 27.71K shares 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | 283.79K shares 10-K · filed 2017-03-16 | |||
| 2015-12-31 | -179.50K shares 10-K · filed 2016-03-15 | |||
| 2014-12-31 | -340.50K shares 10-K · filed 2016-03-15 | |||
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-15 | -130.00K shares derived: sum of 2 quarters · filed 2015-03-12 | -11.33K shares derived: sum of 3 quarters · filed 2015-03-12 | -130.00K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-12-31 | -130.00K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-12 | -11.33K shares derived: sum of 2 quarters · filed 2015-03-12 | -130.00K shares derived: sum of 3 quarters · filed 2015-03-12 | -367.33K shares 10-K · filed 2015-03-12 |
| 2013-09-30 | 118.67K shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2014-03-04 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-04 | -237.33K shares 10-Q/A · filed 2014-03-04 | -237.33K shares derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-06-30 | -118.67K shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-03-04 | -356.00K shares 10-Q/A · filed 2014-03-04 | -356.00K shares derived: sum of 3 quarters · filed 2014-05-15 | -356.00K shares derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-03-31 | -237.33K shares 10-Q · filed 2014-05-15 | -237.33K shares derived: sum of 2 quarters · filed 2014-05-15 | -237.33K shares derived: sum of 3 quarters · filed 2014-05-15 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-31 | -263.05K shares 10-K · filed 2014-03-31 | |
| 2012-09-30 | 0.00 shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2014-03-04 | -263.05K shares 10-Q/A · filed 2014-03-04 | ||
| 2012-06-30 | -263.05K shares 10-Q/A · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |